312 related articles for article (PubMed ID: 26806303)
1. Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.
Liu R; Proud CG
Acta Pharmacol Sin; 2016 Mar; 37(3):285-94. PubMed ID: 26806303
[TBL] [Abstract][Full Text] [Related]
2. Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases.
Beretta S; Gritti L; Verpelli C; Sala C
Neuroscience; 2020 Oct; 445():42-49. PubMed ID: 32088293
[TBL] [Abstract][Full Text] [Related]
3. Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer.
Fu LL; Xie T; Zhang SY; Liu B
Apoptosis; 2014 Oct; 19(10):1527-31. PubMed ID: 25023961
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target.
Karakas D; Ozpolat B
J Mol Med (Berl); 2020 Jun; 98(6):775-787. PubMed ID: 32377852
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting Eukaryotic Elongation Factor 2 Kinase: An Update on Pharmacological Small-Molecule Compounds in Cancer.
Zhu S; Liao M; Tan H; Zhu L; Chen Y; He G; Liu B
J Med Chem; 2021 Jul; 64(13):8870-8883. PubMed ID: 34162208
[TBL] [Abstract][Full Text] [Related]
6. Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy.
Zhang B; Zou J; Zhang Q; Wang Z; Wang N; He S; Zhao Y; Naman CB
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673713
[TBL] [Abstract][Full Text] [Related]
7. Regulated stability of eukaryotic elongation factor 2 kinase requires intrinsic but not ongoing activity.
Wang X; Xie J; da Mota SR; Moore CE; Proud CG
Biochem J; 2015 Apr; 467(2):321-31. PubMed ID: 25670349
[TBL] [Abstract][Full Text] [Related]
8. [Eukaryotic elongation factor 2 kinase and cancer].
Wang GZ; Qi X; Li J
Yao Xue Xue Bao; 2015 Jul; 50(7):808-13. PubMed ID: 26552140
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles.
Kenney JW; Moore CE; Wang X; Proud CG
Adv Biol Regul; 2014 May; 55():15-27. PubMed ID: 24853390
[TBL] [Abstract][Full Text] [Related]
10. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.
Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH
Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587
[TBL] [Abstract][Full Text] [Related]
11. Novel inhibitors of eukaryotic elongation factor 2 kinase: In silico, synthesis and in vitro studies.
Onder FC; Durdagi S; Kahraman N; Uslu TN; Kandemir H; Atici EB; Ozpolat B; Ay M
Bioorg Chem; 2021 Nov; 116():105296. PubMed ID: 34488125
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer.
Guo Y; Zhao Y; Wang G; Chen Y; Jiang Y; Ouyang L; Liu B
Eur J Med Chem; 2018 Jan; 143():402-418. PubMed ID: 29202403
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanism for the Control of Eukaryotic Elongation Factor 2 Kinase by pH: Role in Cancer Cell Survival.
Xie J; Mikolajek H; Pigott CR; Hooper KJ; Mellows T; Moore CE; Mohammed H; Werner JM; Thomas GJ; Proud CG
Mol Cell Biol; 2015 May; 35(10):1805-24. PubMed ID: 25776553
[TBL] [Abstract][Full Text] [Related]
14. Regulation and roles of elongation factor 2 kinase.
Proud CG
Biochem Soc Trans; 2015 Jun; 43(3):328-32. PubMed ID: 26009171
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells.
Zhu H; Yang X; Liu J; Zhou L; Zhang C; Xu L; Qin Q; Zhan L; Lu J; Cheng H; Sun X
Cell Stress Chaperones; 2015 Mar; 20(2):217-20. PubMed ID: 25248493
[TBL] [Abstract][Full Text] [Related]
16. Discovery of new substrates of the elongation factor-2 kinase suggests a broader role in the cellular nutrient response.
Lazarus MB; Levin RS; Shokat KM
Cell Signal; 2017 Jan; 29():78-83. PubMed ID: 27760376
[TBL] [Abstract][Full Text] [Related]
17. Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy.
Moore CE; Wang X; Xie J; Pickford J; Barron J; Regufe da Mota S; Versele M; Proud CG
Cell Signal; 2016 Apr; 28(4):284-93. PubMed ID: 26795954
[TBL] [Abstract][Full Text] [Related]
18. Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling.
Wang X; Regufe da Mota S; Liu R; Moore CE; Xie J; Lanucara F; Agarwala U; Pyr Dit Ruys S; Vertommen D; Rider MH; Eyers CE; Proud CG
Mol Cell Biol; 2014 Nov; 34(22):4088-103. PubMed ID: 25182533
[TBL] [Abstract][Full Text] [Related]
19. Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia.
Moore CE; Mikolajek H; Regufe da Mota S; Wang X; Kenney JW; Werner JM; Proud CG
Mol Cell Biol; 2015 May; 35(10):1788-804. PubMed ID: 25755286
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis.
Xie J; Shen K; Lenchine RV; Gethings LA; Trim PJ; Snel MF; Zhou Y; Kenney JW; Kamei M; Kochetkova M; Wang X; Proud CG
Int J Cancer; 2018 May; 142(9):1865-1877. PubMed ID: 29235102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
